Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
622 hedge funds and large institutions have $19.3B invested in Exact Sciences in 2020 Q4 according to their latest regulatory filings, with 146 funds opening new positions, 211 increasing their positions, 176 reducing their positions, and 37 closing their positions.
295% more first-time investments, than exits
New positions opened: 146 | Existing positions closed: 37
39% more capital invested
Capital invested by funds: $14B → $19.3B (+$5.38B)
20% more funds holding
Funds holding: 517 → 622 (+105)
20% more repeat investments, than reductions
Existing positions increased: 211 | Existing positions reduced: 176
11% more call options, than puts
Call options by funds: $327M | Put options by funds: $294M
0.07% less ownership
Funds ownership: 91.77% → 91.7% (-0.07%)
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$578M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$359M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$210M |
| 4 |
CC
Casdin Capital
New York
|
+$180M |
| 5 |
JP Morgan Chase
New York
|
+$179M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$423M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$306M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$246M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$188M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$63.7M |
EXAS Hedge Fund Activity: Q4 2020 in Review
622 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2020, worth a combined $19.3B — up 39% from $14B a quarter earlier.
Buyers outnumbered sellers: 146 funds opened new EXAS positions and 37 closed out — a net gain of 109 holders — while 211 added to existing stakes and 176 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $578M. The largest seller was T. Rowe Price Associates, cutting an estimated $423M.
- 622 institutional investors held Exact Sciences (EXAS) as of Q4 2020, up from 517 in Q3 2020.
- Funds reported $19.3B of Exact Sciences stock for Q4 2020, up 39% quarter-over-quarter.
- 146 funds opened new Exact Sciences positions in Q4 2020 and 37 closed out, a net change of +109 holders.
- The largest Exact Sciences buyer in Q4 2020 was ARK Investment Management, an estimated $578M added.
- The largest Exact Sciences seller in Q4 2020 was T. Rowe Price Associates, an estimated $423M sold.
Based on aggregated 13F filings for Q4 2020.